The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Co-Danthramer 75mg/1000mg per 5ml Oral Suspension

Pinewood Laboratories Ltd,PA0281/080/002

Main Information

Trade NameCo-Danthramer 75mg/1000mg per 5ml Oral Suspension
Active SubstancesDantron
Poloxamer 188
Dosage FormOral suspension
Licence HolderPinewood Laboratories Ltd,
Licence NumberPA0281/080/002

Group Information

ATC CodeA06AB Contact laxatives
A06AB53 dantron, combinations


License statusAuthorised
Licence Issued08/12/2000
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back